Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis
- 19 January 2009
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 15 (4) , 431-436
- https://doi.org/10.1177/1352458508100037
Abstract
Background Both human leukocyte antigen (HLA)-DRB1*15 and Epstein-Barr virus infection presenting as infectious mononucleosis (IM) are recognized as risk factors for multiple sclerosis (MS). However, their combined effect and possible interaction on MS risk is not known. Objective To assess the association between HLA-DRB1*15 and risk of MS in persons with and without IM. Methods We compared the prevalence of DRB1*15 in MS patients with (n = 76) and without (n = 1,836) IM with the corresponding distributions in blood donors with (n = 62) and without (n = 484) IM histories. This allowed us to estimate the relative risk of MS associated with DRB1*15 in the presence and absence, respectively, of previous IM. We then estimated the interaction between DRB1*15 and IM as the ratio of the two individual odds ratios. Results In IM-naïve individuals, DRB1*15 carried a 2.4-fold (95% confidence interval [CI], 2.0–3.0) increased MS risk. In contrast, among persons with IM history, DRB1*15 was associated with a 7.0-fold (95% CI, 3.3–15.4) increased MS risk. Thus, the MS risk conferred by HLA-DRB1*15 was 2.9 (95% CI, 1.3–6.5)-fold stronger in the presence than in the absence of IM. Combined with previous results, this result indicates that DRB1*15-positive persons with a history of IM may be at a 10.0-fold (95% CI, 6.0–17.9) increased risk of MS compared with persons who are DRB1*15 and IM-naïve. Conclusion DRB1*15 and IM may act in synergy causing MS.Keywords
This publication has 38 references indexed in Scilit:
- HLA-AB and -DR types in patients with infectious mononucleosis (IM)Tissue Antigens, 2008
- Improving health profile of blood donors as a consequence of transfusion safety effortsTransfusion, 2007
- Multiple sclerosis after infectious mononucleosis: record linkage studyJournal of Epidemiology and Community Health, 2004
- A functional and structural basis for TCR cross-reactivity in multiple sclerosisNature Immunology, 2002
- A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosisGenes & Immunity, 2002
- The Danish Multiple Sclerosis Registry: a 50-year follow-upMultiple Sclerosis Journal, 1999
- HLA gene and haplotype frequencies in bone marrow donors worldwide registriesHuman Immunology, 1997
- Non‐hierarchical logistic models and case‐only designs for assessing susceptibility in population‐based case‐control studiesStatistics in Medicine, 1994
- Molecular mimicry and autoimmune diseaseCell, 1987
- HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO CLINICAL COURSEThe Lancet, 1973